In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk. The model, called ...
Biolojic Design, a biotechnology company that uses AI to transform antibodies into multifunctional, programmable medicines, ...
Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line ...
Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion ...
Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...
Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.